In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics - PubMed (original) (raw)
Comparative Study
. 2001 Aug 7;40(31):9256-64.
doi: 10.1021/bi002885x.
Affiliations
- PMID: 11478893
- DOI: 10.1021/bi002885x
Comparative Study
In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics
J D Artz et al. Biochemistry. 2001.
Abstract
Nitric oxide (NO) performs a central role in biological systems, binding to the heme site of soluble guanylyl cyclase (sGC), leading to enzyme activation and elevation of intracellular levels of cGMP. Organic nitrates, in particular, nitroglycerin (GTN), are clinically important nitrovasodilators that function as NO-mimetics in biological systems. Comparison of sGC activation data with electrochemically measured rates of NO release for genuine NO donors, NONOates and nitrosothiols, yields an excellent correlation between the EC(50) for sGC activation and the rate constant for NO release, k(NO). However, activation of sGC by GTN and the nitrates has very different characteristics, including the requirement for specific added thiols, for example, cysteine. The reaction of GTN with cysteine in anaerobic solution yields NO slowly, and NO release, measured by chemiluminescence detection, is quenched by added metal ion chelator. The generation of NO under aerobic conditions is 100-fold slower than the anaerobic reaction. Furthermore, NO release from the reaction of GTN with cysteine in phosphate buffer is too slow to account for sGC activation by GTN/cysteine. The slow rate of the chemical reaction to release NO suggests that nitrates can activate sGC by an NO-independent mechanism. In contrast to the genuine NO donors, GTN behaves as a partial agonist with respect to sGC activation, but in the presence of the allosteric sGC activator, YC-1, GTN exhibits full agonist activity.
Similar articles
- Effects of nitroglycerin/L-cysteine on soluble guanylate cyclase: evidence for an activation/inactivation equilibrium controlled by nitric oxide binding and haem oxidation.
Gorren AC, Russwurm M, Kollau A, Koesling D, Schmidt K, Mayer B. Gorren AC, et al. Biochem J. 2005 Sep 1;390(Pt 2):625-31. doi: 10.1042/BJ20050565. Biochem J. 2005. PMID: 15907191 Free PMC article. - Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance.
Sayed N, Kim DD, Fioramonti X, Iwahashi T, Durán WN, Beuve A. Sayed N, et al. Circ Res. 2008 Sep 12;103(6):606-14. doi: 10.1161/CIRCRESAHA.108.175133. Epub 2008 Jul 31. Circ Res. 2008. PMID: 18669924 Free PMC article. - Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells.
Schmidt K, Schrammel A, Koesling D, Mayer B. Schmidt K, et al. Mol Pharmacol. 2001 Feb;59(2):220-4. doi: 10.1124/mol.59.2.220. Mol Pharmacol. 2001. PMID: 11160856 - Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction.
Gur S, Kadowitz PJ, Hellstrom WJ. Gur S, et al. Curr Pharm Des. 2010 May;16(14):1619-33. doi: 10.2174/138161210791164162. Curr Pharm Des. 2010. PMID: 20201788 Review. - NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.
Evgenov OV, Pacher P, Schmidt PM, Haskó G, Schmidt HH, Stasch JP. Evgenov OV, et al. Nat Rev Drug Discov. 2006 Sep;5(9):755-68. doi: 10.1038/nrd2038. Nat Rev Drug Discov. 2006. PMID: 16955067 Free PMC article. Review.
Cited by
- Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases.
Kopra K, Sharina I, Martin E, Härmä H. Kopra K, et al. Sci Rep. 2020 Oct 15;10(1):17469. doi: 10.1038/s41598-020-74611-x. Sci Rep. 2020. PMID: 33060787 Free PMC article. - Structural insights into the mechanism of human soluble guanylate cyclase.
Kang Y, Liu R, Wu JX, Chen L. Kang Y, et al. Nature. 2019 Oct;574(7777):206-210. doi: 10.1038/s41586-019-1584-6. Epub 2019 Sep 12. Nature. 2019. PMID: 31514202 - Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery.
Hollas MA, Ben Aissa M, Lee SH, Gordon-Blake JM, Thatcher GRJ. Hollas MA, et al. Nitric Oxide. 2019 Jan 1;82:59-74. doi: 10.1016/j.niox.2018.10.006. Epub 2018 Oct 28. Nitric Oxide. 2019. PMID: 30394348 Free PMC article. Review. - Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
Ben Aissa M, Tipton AF, Bertels Z, Gandhi R, Moye LS, Novack M, Bennett BM, Wang Y, Litosh V, Lee SH, Gaisina IN, Thatcher GR, Pradhan AA. Ben Aissa M, et al. Cephalalgia. 2018 Jul;38(8):1471-1484. doi: 10.1177/0333102417737778. Epub 2017 Oct 12. Cephalalgia. 2018. PMID: 29022756 Free PMC article. - Sub-Nanomolar Sensitivity of Nitric Oxide Mediated Regulation of cGMP and Vasomotor Reactivity in Vascular Smooth Muscle.
Held KF, Dostmann WR. Held KF, et al. Front Pharmacol. 2012 Jul 12;3:130. doi: 10.3389/fphar.2012.00130. eCollection 2012. Front Pharmacol. 2012. PMID: 22807915 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources